These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28188811)

  • 1. Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia.
    Morera-Fumero AL; Díaz-Mesa E; Abreu-Gonzalez P; Fernandez-Lopez L; Cejas-Mendez MDR
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():207-212. PubMed ID: 28188811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patients.
    Morera-Fumero AL; Diaz-Mesa E; Fernandez-Lopez L; Abreu-Gonzalez P; Henry-Benitez MS
    Acta Neuropsychiatr; 2023 Jun; 35(3):138-146. PubMed ID: 36503534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapse.
    Morera-Fumero AL; Díaz-Mesa E; Abreu-Gonzalez P; Fernandez-Lopez L; Cejas-Mendez MD
    Psychiatry Res; 2017 Mar; 249():200-205. PubMed ID: 28126575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE.
    Steiner J; Walter M; Wunderlich MT; Bernstein HG; Panteli B; Brauner M; Jacobs R; Gos T; Rothermundt M; Bogerts B
    Biol Psychiatry; 2009 Jun; 65(12):1107-10. PubMed ID: 19103440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.
    Morera-Fumero AL; Díaz-Mesa E; Abreu-Gonzalez P; Fernandez-Lopez L; Guillen-Pino F
    PLoS One; 2017; 12(12):e0189348. PubMed ID: 29220388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrations.
    Morera-Fumero AL; Díaz-Mesa E; Abreu-González P; Fernandez-Lopez L
    Actas Esp Psiquiatr; 2021 Sep; 49(5):211-215. PubMed ID: 34533204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia.
    Rothermundt M; Ponath G; Glaser T; Hetzel G; Arolt V
    Neuropsychopharmacology; 2004 May; 29(5):1004-11. PubMed ID: 14997170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summer/winter changes in serum S100B protein concentration as a source of research variance.
    Morera-Fumero AL; Abreu-Gonzalez P; Henry-Benitez M; Yelmo-Cruz S; Diaz-Mesa E
    J Psychiatr Res; 2013 Jun; 47(6):791-5. PubMed ID: 23523337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum S100B in never-medicated and medicated schizophrenic patients.
    Zhang XY; Xiu MH; Song C; Chen DC; Wu GY; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2010 Dec; 44(16):1236-40. PubMed ID: 20510426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels.
    Steiner J; Westphal S; Schroeter ML; Schiltz K; Jordan W; Müller UJ; Bernstein HG; Bogerts B; Schmidt RE; Jacobs R
    Brain Behav Immun; 2012 May; 26(4):564-7. PubMed ID: 22326439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.
    Rothermundt M; Missler U; Arolt V; Peters M; Leadbeater J; Wiesmann M; Rudolf S; Wandinger KP; Kirchner H
    Mol Psychiatry; 2001 Jul; 6(4):445-9. PubMed ID: 11443531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
    Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
    Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100B and schizophrenia.
    Yelmo-Cruz S; Morera-Fumero AL; Abreu-González P
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):67-75. PubMed ID: 23438158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Zhang XY; Xiu MH; Chen DC; Zhu FY; Wu GY; Haile CN; Lu L; Kosten TA; Kosten TR
    J Psychiatr Res; 2010 May; 44(7):429-33. PubMed ID: 19932492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers.
    Hong W; Zhao M; Li H; Peng F; Wang F; Li N; Xiang H; Su Y; Huang Y; Zhang S; Zhao G; Zhou R; Mao L; Lin Z; Fang Y; Zhang Q; Xie B
    Sci Rep; 2016 Jun; 6():27584. PubMed ID: 27279465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms.
    Schmitt A; Bertsch T; Henning U; Tost H; Klimke A; Henn FA; Falkai P
    Schizophr Res; 2005 Dec; 80(2-3):305-13. PubMed ID: 15964742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
    Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness.
    van de Kerkhof NW; Fekkes D; van der Heijden FM; Verhoeven WM
    Acta Neuropsychiatr; 2014 Aug; 26(4):223-9. PubMed ID: 25142290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100B and homocysteine in the acute alcohol withdrawal syndrome.
    Wedekind D; Neumann K; Falkai P; Malchow B; Engel KR; Jamrozinski K; Havemann-Reinecke U
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):133-8. PubMed ID: 20593192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
    Chen S; Tian L; Chen N; Xiu M; Wang Z; Yang G; Wang C; Yang F; Tan Y
    Psychiatry Res; 2017 Jan; 247():6-11. PubMed ID: 27863321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.